Annual Report • Apr 29, 2021
Annual Report
Open in ViewerOpens in native device viewer
| 2020 | 2019 | |
|---|---|---|
| € | € | |
| Gain on restructuring of bank loans | 1.527.238 | - |
| Other operating income | 31.698 | 49.532 |
| Administrative expenses | (43.419) | (43.355) |
| Net gain / (loss) on financial assets at fair value through profit and loss |
180 | (3.204) |
| Profit from operations | 1.515.697 | 2.973 |
| Net finance costs | (139.495) | (242.513) |
| Profit / (loss) before taxation | 1.376.202 | (239.540) |
| Taxation | - | 7.616 |
| Net profit / (loss) for the year |
1.376.202 | (231.924) |
| Other total income | - | - |
| Total income / (expenses) for the year |
1.376.202 | (231.924) |
| Basic and fully diluted earnings / (loss) per share (€) | 13.78 | (2.32) |
| 2020 | 2019 | |
|---|---|---|
| € | € | |
| ASSETS | ||
| Current assets | ||
| Inventories | - | 1.665.660 |
| Trade and other receivables | 97.949 | 33.405 |
| Loans to holding company | 136.096 | 1.254.025 |
| Financial assets at fair value through profit and loss |
1.300 | 1.120 |
| Cash at bank and in hand | 331 | 12.820 |
| Total assets | 235.676 | 2.967.030 |
| 235.676 | 2.967.030 | |
| EQUITY AND LIABILITIES | ||
| Equity | ||
| Share capital | 499.392 | 499.392 |
| Share premium reserve | 807.523 | 807.523 |
| Foreign exchange reserve | 12.565 | 12.565 |
| Accumulated losses | (1.197.831) | (2.574.033) |
| Total equity | 121.649 | (1.254.553) |
| Non-Current Liabilities | ||
| Borrowings | 101.872 | - |
| 101.872 | - | |
| Current liabilities | ||
| Trade and other creditors | 6.527 | 15.589 |
| Borrowings | - | 4.200.366 |
| Current tax liabilities | 5.628 | 5.628 |
| 12.155 | 4.221.583 | |
| Total liabilities | 114.027 | 4.221.583 |
| Total equity and liabilities | 235.676 | 2.967.030 |
| Share premium |
Foreign exchange |
Accumulated | |||
|---|---|---|---|---|---|
| Share capital | reserve | reserve | losses | Total | |
| € | € | € | € | € | |
| Balance as at 1 January 2019 | 499.392 | 807.523 | 12.565 | (2.342.109) | (1.022.629) |
| Total income | |||||
| Net loss for the year | - | - | - | (231.924) | (231.924) |
| Total income for the year | - | - | - | (231.924) | (231.924) |
| Balance as at 31 December 2019 / 1 January 2020 |
499.392 | 807.523 | 12.565 | (2.574.033) | (1.254.553) |
| Total income | |||||
| Net profit for the year | - | - | - | 1.376.202 | 1.376.202 |
| Total income for the year | - | - | - | 1.376.202 | 1.376.202 |
| Balance as at 31 December 2020 | 499.392 | 807.523 | 12.565 | (1.197.831) | 121.649 |
The share premium reserve and the foreign exchange reserve are not available for distribution.
Companies which do not distribute 70% of their profits after tax, as defined by the Special Contribution for Defence Law of the Republic, within two years after the end of the relevant tax year, will be deemed to have distributed this amount as dividend. The amount of deemed dividend distribution is reduced by any actual dividend already distributed by the 31st of December of the second year for the year to which the profits relate.
A special contribution for defence of 17% (applicable from 2014 onwards) on the amount of the deemed dividend distribution is paid by the Company for the account of the shareholders, in case the shareholders concerned are natural persons who are Cyprus tax residents and are domiciled in Cyprus. In addition, since 2019 (deemed dividend distribution of profits for 2017) a contribution to the General Health System (GESY) at 2.65% (rate as at 31 December 2019: 1.70%) is paid by the Company for the account of the shareholders, in case the shareholders concerned are natural persons who are Cyprus tax residents, irrespective of their domicile.
| 2020 | 2019 | |
|---|---|---|
| € | € | |
| CASH FLOW FROM OPERATIONS | ||
| Profit / (loss) before taxation | 1.376.202 | (239.540) |
| Adjustments for: | ||
| Gain on restructuring of bank loans | (1.527.238) | - |
| Credit interest | (31.698) | (49.532) |
| Debit interest | 139.495 | 242.513 |
| (43.239) | (46.559) | |
| Changes in working capital: | ||
| Proceeds from loans to holding company | 39.575 | 39.463 |
| (Increase) / decrease in financial assets at fair value through profit and Loss |
(180) | 3.204 |
| (Decrease) / increase in trade and other creditors | (9.060) | 507 |
| Tax refundable | - | 13.367 |
| Cash (for) / from operations |
(12.904) | 9.982 |
| CASH FLOW FROM INVESTING ACTIVITIES | - | - |
| CASH FLOW FROM FINANCING ACTIVITIES | ||
| Loan repayments | (667) | - |
| Other borrowing charges | 1.082 | 1.412 |
| Net cash from financing activities |
415 | 1.412 |
| Net (decrease) / increase in cash and cash equivalents |
(12.489) | 11.394 |
| Cash and cash equivalents at beginning of year | 12.820 | 1.426 |
| Cash and cash equivalents at end of year |
331 | 12.820 |
| Non financial transactions | 2020 | 2019 |
| € | € | |
| Write-off of loans | 4.200.366 | - |
| Write-off of interest | 137.787 | - |
| Write-off of expenses | 251 | - |
| Transfer of reserves | (1.665.660) | - |
| Repayment by holding company | (705.800) | - |
| New borrowings | (100.000) | - |
| Increase in other receivables |
64.544 | - |
| Restructuring costs | (404.251) | - |
| Gain on write-off of loans | (1.527.238) | - |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.